3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
23
Recruiting
6
Terminated
5
Withdrawn
3
Unknown
3
Active not recruiting
2
Suspended
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasm Metastasis
3
Oropharyngeal Neoplasms
2
Lymphoma, Follicular
2
Glioblastoma
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Locally Recurrent Skin Squamous Cell Carcinoma
1
HTLV-I Infections
1
Eyelid Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Carcinoma In Situ
1
Astrocytoma
1
Anatomic Stage III Breast Cancer AJCC v8
1
Adenocarcinoma of Lung
1
Interventions
E 7107
2
Carboplatin
2
palbociclib
1
gedatolisib
1
eniluracil
1
dabrafenib
1
abarelix
1
Topotecan
1
Standard of Care
1
Radionuclide Imaging
1
Radiofrequency Ablation
1
Practice Guidelines as Topic
1
Positron-Emission Tomography
1
Passive Cutaneous Anaphylaxis
1
Paclitaxel
1
NUC-1031
1
Morphine
1
Methadone
1
Maltose
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
KB004
1
Injections
1
Infusions, Parenteral
1
Hyperthermic Intraperitoneal Chemotherapy
1
Hydromorphone
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
Flucytosine
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT05887882
2026-04-24
PNOC028
University of California, San Francisco
Phase 1
Suspended
24 enrolled